Log in to save to my catalogue

Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β

Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_863901793

Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β

About this item

Full title

Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β

Publisher

United States

Journal title

Nature neuroscience, 2011-05, Vol.14 (5), p.545-547

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

Amyloid-β(1-42) (Aβ) is thought to be a major mediator of the cognitive deficits in Alzheimer's disease. The ability of Aβ to inhibit hippocampal long-term potentiation provides a cellular correlate of this action, but the underlying molecular mechanism is only partially understood. We found that a signaling pathway involving caspase-3, Akt1 and gl...

Alternative Titles

Full title

Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_863901793

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_863901793

Other Identifiers

E-ISSN

1546-1726

DOI

10.1038/nn.2785

How to access this item